This is an EDITABLE stock research wiki. You can contribute by clicking on the EDIT PAGE link above or on the page icons that appear when you roll over one of the category subtitles below.
From 1
Company Information:
Company Address:
63 2nd Ave.
Burlington, MA 01803
Company’s Web Address: http://www.lemaitre.com/
Industry Sector:
Fiscal Year:
Dividend:
Note: this section is not editable.
Please click here to report any inaccuracies.
Company Overview:
Company Products/Services/Markets:
Enter Company Products/Services Here
Strategy:
Describe Key Aspects of Company's Strategy Here
Competitors:
Enter Competitors Here
Industry Trends and News:
Enter Industry Trends and News Here
Acquisitions, Divestitures, Major Transactions, Spin-offs :
Enter Acquisitions, Divestiures, Major Transactions, Spin-offs Here
Management – Pros & Cons, Changes:
Enter Management - Pros & Cons, Changes Here
Financial Analysis:
Enter Financial Analysis Here
Valuation:
Enter Valuation Analysis and Valuation Ratios Here
| |
2007
|
2006
|
2005
|
| Price/Earnings |
|
|
|
| Price/EBITDA |
|
|
|
| Price/Pre-tax Income |
|
|
|
| Price/Revenue |
|
|
|
Investment Rationale:
Buy Rationale:
Enter Buy Rationale Here
Sell Rationale:
Enter Sell Rationale Here
Projected Financials:
Income Statement: (Paste Here)
Balance Sheet: (Paste Here)
Cash Flow Statement: (Paste Here)
Financial Ratios: (Paste Here)
Other: (Paste Here)
Discussion:
This area is for debates regarding different recommendations for this stock.
News:
|
Yahoo! Finance: LMAT News
|
LeMaitre Vascular, Inc. Earnings Call scheduled for Tue, July 29 (CCBN)
|
LeMaitre Vascular, Inc. Schedules Second Quarter Results and Conference Call (PrimeNewswire)
BURLINGTON, Mass., July 17, 2008 -- LeMaitre Vascular, Inc. announced today that it will release its 2008 second quarter financial results on July 29, 2008, after the close of the market.
|
LEMAITRE VASCULAR INC Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online)
|
Coverage initiated on Lemaitre Vascular by Jesup & Lamont (Briefing.com)
|
LeMaitre Vascular to Participate in 29th Annual Goldman Sachs Global Healthcare Conference (PR Newswire)
LeMaitre Vascular, Inc. , which develops, manufactures, and markets medical devices and implants for the treatment of peripheral vascular disease, is scheduled to participate in the Twenty-Ninth Annual Goldman Sachs Health Care Conference on Tuesday, June 10, 2008, at the Ritz-Carlton Laguna Niguel in Dana Point, California.
|
LEMAITRE VASCULAR INC Financials (EDGAR Online Financials)
|
LEMAITRE VASCULAR INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)
|
LEMAITRE VASCULAR INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh (EDGAR Online)
|
LeMaitre Vascular, Inc. Earnings Call scheduled for 5:00 pm ET today (CCBN)
|
LeMaitre Vascular Reports Q1 2008 Revenue of $11.8 Million, a 20% Increase (PR Newswire)
LeMaitre Vascular, Inc. , a provider of peripheral vascular devices and implants, today announced financial results for Q1 2008. Q1 2008 revenues were $11.8 million, an increase of 20% over Q1 2007.
|
Q1 2008 LeMaitre Vascular, Inc. Earnings Release - After Market Close (CCBN)
|
LEMAITRE VASCULAR INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principa (EDGAR Online)
|
Today's 5-Star Movers (at Motley Fool)
|
LEMAITRE VASCULAR INC Files SEC form 10-K, Annual Report (EDGAR Online)
|
LEMAITRE VASCULAR INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Princ (EDGAR Online)
|
LEMAITRE VASCULAR INC Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (EDGAR Online)
|
LEMAITRE VASCULAR INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financ (EDGAR Online)
|
5 Low-Priced, Five-Star Stocks (at Motley Fool)
|
LEMAITRE VASCULAR INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)
|
LEMAITRE VASCULAR INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh (EDGAR Online)
|
See Also (links to blogs, forums, external sources, etc...):
The opinions and views expressed in this document do not necessarily reflect the views or opinions of InvestingMinds. InvestingMinds did not prepare and does not endorse such content. Please note that it is intended for general circulation only and the recommendations contained herein do not take into account the specific investment objectives, financial situation or particular needs of any particular person. This document is for information purposes only and it should not be regarded as an offer to sell or as a solicitation of an offer to buy securities or other instruments. No part of this document may be reproduced in any manner without the written permission of InvestingMinds.
